Viktor Sandblom

Local treatment of liver metastases by administration of 177Lu-octreotate via isolated hepatic perfusion – A preclinical simulation of a novel treatment

strategy

Viktor Sandblom, Ingun Ståhl, Christoffer Hansson, Roger Olofsson Bagge, Eva Forssell-Aronsson
Surgical Oncology - 2019

177Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90

inhibition

Tobias Hofving, Viktor Sandblom, Yvonne Arvidsson, Emman Shubbar, Gülay Altiparmak, John Swanpalmer, Bilal Almobarak, Anna-Karin Elf, Viktor Johanson, Erik Elias, Erik Kristiansson, Eva Forssell-Aronsson, Ola Nilsson
Endocrine-Related Cancer - 2019

Tyrosine kinase inhibitors can potentially increase the effect from radiation therapy on medullary thyroid

cancer

Viktor Sandblom, Johan Spetz, Emman Shubbar, Mikael Montelius, Ingun Ståhl, John Swanpalmer, Ola Nilsson, Eva Forssell-Aronsson
Gothenburg Cancer Meeting. 6-7th May 2019 - 2019

Tyrosinkinashämmare kan öka effekten från strålbehandling av medullär

tyreoideacancer

Viktor Sandblom, Johan Spetz, Emman Shubbar, Mikael Montelius, Ingun Ståhl, John Swanpalmer, Ola Nilsson, Eva Forssell-Aronsson
Nationellt möte om sjukhusfysik - 2019

Strategies for optimisation of 177Lu-octreotate therapy – exploring local administration and combination therapy

regimens

Viktor Sandblom
2019

The effect of timing and sequence of gemcitabine administration and ionizing radiation for more efficient treatment of medullary thyroid

carcinoma

Emman Shubbar, Viktor Sandblom, John Swanpalmer, Eva Forssell-Aronsson
Gothenburg Cancer Meeting - 2019

Radiolabeled somatostatin analogue binding and internalization in human tumor cell

lines

Sofia Saadati, Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer, Bengt Hallberg, Khalil Helou, Eva Forssell-Aronsson
Gothenburg Cancer Meeting 2019, Gothenburg, Sweden - 2019

Molecular targeting of various human tumor cell lines with

177Lu-octreotate

Sofia Saadati, Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer, Bengt Hallberg, Khalil Helou, Eva Forssell-Aronsson
Annual Congress of the European Association of Nuclear Medicine October 13 - 17, 2018 Düsseldorf, Germany - 2018

Vandetanib may act as radiosensitiser for 177Lu-octreotate treatment of medullary thyroid

cancer

Viktor Sandblom, Johan Spetz, Emman Shubbar, Ingun Ståhl, John Swanpalmer, Eva Forssell-Aronsson
2nd European Congress of Medical Physics. Physica Medica Vol. 52, Suppl. 1, pp. 62-63 - 2018

The effect of timing and sequence of gemcitabine administration and radiation for the treatment of medullary thyroid

carcinoma.

Emman Shubbar, Viktor Sandblom, John Swanpalmer, Eva Forssell-Aronsson
European Journal of Nuclear Medicine and Molecular Imaging - 2018

Optimization of treatment of neuroendocrine tumors with radiolabeled somatostatin

analogues

Eva Forssell-Aronsson, Johan Spetz, Viktor Sandblom, Britta Langen, Khalil Helou, Bo Wängberg, Ola Nilsson
Global Academics Programs Conference, Stockholm, May 15-17, 2018. - 2018

Evaluation of two intraoperative gamma detectors for assessment of 177Lu activity concentration in

vivo

Viktor Sandblom, Ingun Ståhl, Roger Olofsson Bagge, Eva Forssell-Aronsson
European Journal of Nuclear Medicine and Molecular Imaging Physics - 2017

Combination therapy of medullary thyroid cancer using radiation and

vandetanib

Viktor Sandblom, Johan Spetz, Emman Shubbar, John Swanpalmer, Eva Forssell-Aronsson
European Journal of Nuclear Medicine and Molecular Imaging. Annual Congress of the European Association of Nuclear Medicine October 21 – 25, 2017 Vienna, Austria. Vol. 44, Suppl. 2. EP-0792 - 2017

In vitro screening for Lu-177-octreotate uptake in human tumor cell

lines

Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer, Bengt Hallberg, Khalil Helou, Eva Forssell-Aronsson
Cancerfondens Planeringsgrupp för Onkologisk Radionuklidterapi höstmöte 2017 - 2017

Administration of 177Lu-octreotate via isolated hepatic perfusion – an experimental pilot study of activity concentration measurements in liver of

pig

Viktor Sandblom, Ingun Ståhl, Christoffer Hansson, Roger Olofsson, Eva Forssell-Aronsson
Nationellt möte om sjukhusfysik. Västerås, 15-17 november - 2017

Binding and internalization of 177Lu-octreotate in human tumor cell lines of different

origin

Sofia Saadati, Johan Spetz, Viktor Sandblom, Emil Schüler, Ruth H. Palmer, Bengt Hallberg, Khalil Helou, Eva Forssell-Aronsson
63rd Annual Meeting of the Radiation Research Society, Cancun, Mexico - 2017

Treatment of medullary thyroid cancer using a combination of radiation and

gemcitabine

Viktor Sandblom, Johan Spetz, John Swanpalmer, Eva Forssell-Aronsson
62nd Annual International Meeting Radiation Research Society 2016. Big Island, Hawaii, USA, October 16-19, 2016 - 2016

Investigation of potential synergistic effects of combining gemcitabine with irradiation for medullary thyroid

cancer

Viktor Sandblom, Johan Spetz, John Swanpalmer, Eva Forssell-Aronsson
Swedish Cancer Society autumn meeting, Uppsala, Sweden. - 2016

Gemcitabine potentiates the anti-tumour effect of radiation therapy on medullary thyroid

cancer

Viktor Sandblom, Johan Spetz, John Swanpalmer, Eva Forssell-Aronsson
4th Swedish Cancer Research Meeting, 7-8 november 2016, Gothenburg, Sweden. - 2016

OPTIMISATION OF OCCUPATIONAL RADIATION PROTECTION IN IMAGE-GUIDED INTERVENTIONS: EXPLORING VIDEO RECORDINGS AS A TOOL IN THE

PROCESS

Anja Almén, Viktor Sandblom, Hans Rystedt, Alexa von Wrangel, Jonas Ivarsson, Magnus Båth, Charlotta Lundh
Radiation protection dosimetry - 2016

Combination therapy of medullary thyroid cancer (MTC) using 177Lu-octreotate and

gemcitabine

Viktor Sandblom, Johan Spetz, Eva Forssell-Aronsson
Cancerfondens planeringsgrupp för onkologisk radionuklidterapi, Höstmöte, Linköping, Sweden, November 25-27, 2015 - 2015

Eye dosimetry and protective eyewear for interventional

clinicians

Colin Martin, Jill Magee, Viktor Sandblom, Anja Almén, Charlotta Lundh
Radiation Protection Dosimetry - 2015

Determination of 177Lu-octreotate activity concentration in vivo using intraoperative gamma probes - a comparative

study

Viktor Sandblom, Ingun Ståhl, Roger Olofsson, Eva Forssell-Aronsson
Cancerfondens planeringsgrupp för onkologisk radionuklidterapis vintermöte 2015, 22-23 januari, Umeå, Sverige. - 2015

Optimisation of occupational radiological protection in image-guided interventions: potential impact of dose rate

measurements.

Anja Almén, Viktor Sandblom, Magnus Båth, Charlotta Lundh
Journal of radiological protection : official journal of the Society for Radiological Protection - 2015

Biokinetics of radiolabeled octreotide and MIBG in patients with metastatic pheochromocytoma and

paragangliomas

Johan Spetz, Viktor Sandblom, Ola Nilsson, Bo Wängberg, Eva Forssell-Aronsson
International Symposium on Pheochromocytoma and Paraganglioma, Kyoto, Japan, September 17-20, 2014 - 2014

Derivation and application of dose reduction factors for protective eyewear worn in interventional radiology and

cardiology.

Jill S Magee, Colin J Martin, Viktor Sandblom, Matthew J Carter, Anja Almén, Åke Cederblad, Pernilla Jonasson, Charlotta Lundh
Journal of radiological protection : official journal of the Society for Radiological Protection - 2014

Treatment of patients with metastatic pheochromocytoma and paragangliomas using radiolabeled somatostatin analogues and

MIBG

Johan Spetz, Viktor Sandblom, Ola Nilsson, Bo Wängberg, Eva Forssell-Aronsson
27th Annual Congress on European Association of Nuclear Medicine, Gothenburg, Sweden, October 18-22, 2014 - 2014

Evaluation of the possibility of using intraoperative gamma probe measurements for determining 177Lu-octreotate activity concentration in

vivo

Viktor Sandblom, Ingun Ståhl, Roger Olofsson, Eva Forssell-Aronsson
27th Annual Congress on European Association of Nuclear Medicine, Gothenburg, Sweden, October 18-22, 2014. - 2014

Feasibility study of intraoperative gamma probes for determining 177Lu-octreotate activity concentration in

vivo

Ingun Ståhl, Viktor Sandblom, Roger Olofsson Bagge, Eva Forssell-Aronsson
SWE-RAYS (Swedish Radiation Research Association for Young Scientists) 3e årliga workshop, Malmö. - 2014

Radiolabelled pharmaceuticals MIBG and octreotate for treatment of metastatic pheochromocytoma and

paraganglioma

Viktor Sandblom, Johan Spetz, Ola Nilsson, Bo Wängberg, Eva Forssell-Aronsson
SweRays Workshop, Malmö, Sweden, Aug 20-22, 2014 - 2014

Biodistribution of 177Lu-octreotate in H69-bearing nude mice- comparison between neuroendocrine tumor

models

Johanna Dalmo, Johan Spetz, Viktor Sandblom, Britta Langen, Bo Wängberg, Ola Nilsson, Eva Forssell-Aronsson
SweRays Workshop, Malmö, Sweden, Aug 20-22, 2014 - 2014

Evaluation of the impact of a system for real-time visualisation of occupational radiation dose rate during fluoroscopically guided

procedures

Viktor Sandblom, Tu Mai, Anja Almén, Hans Rystedt, Åke Cederblad, Magnus Båth, Charlotta Lundh
Nationellt möte om sjukhusfysik 2013, 13-14 november 2013, Varberg - 2013

Visualisering av osynliga risker: optimering av strålskydd för säkrare

arbetsmiljö

Viktor Sandblom, Hans Rystedt, Anja Almén, Magnus Båth, Åsa Mäkitalo, Karin Zachrisson, Kajsa Lindberg, Charlotta Lundh
Röntgenveckan 2013, 3-6 september 2013, Uppsala - 2013

Mätmetoder för bestämning av stråldoser till ögats

lins

Viktor Sandblom, Charlotta Lundh, Anja Almén
2013

Evaluation of the impact of a system for real-time visualisation of occupational radiation dose rate during fluoroscopically guided

procedures

Viktor Sandblom, Tu Mai, Anja Almén, Hans Rystedt, Åke Cederblad, Magnus Båth, Charlotta Lundh
Journal of Radiological Protection - 2013

Evaluation of eye lens doses received by medical staff working in interventional radiology at sahlgrenska university

hospital

Viktor Sandblom, Charlotta Lundh, Åke Cederblad, Pernilla Jonasson
2012